Karen Noblett - Jan 8, 2024 Form 4 Insider Report for Axonics, Inc. (AXNX)

Signature
Kari L. Keese, as Attorney-in-fact for Karen Noblett
Stock symbol
AXNX
Transactions as of
Jan 8, 2024
Transactions value $
-$1,103,961
Form type
4
Date filed
1/10/2024, 08:00 PM
Previous filing
Dec 28, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXNX Common Stock Sale -$1.1M -16K -46.76% $69.00 18.2K Jan 8, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan entered into on September 15, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $69.00 to $69.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.